Evidence map›Paper›PMID 36348992›Full record

SynthesisJournal of interventional cardiology2022

Effect of TAVR Approach and Other Baseline Factors on the Incidence of Acute Kidney Injury: A Systematic Review and Meta-Analysis.

Hossam Alzu'bi, Anan Abu Rmilah, Ikram-Ui Haq, Babikir Kheiri, Ahmad Al-Abdouh, Bashar Hasan, Omar Elsekaily, Suhaib Jaber, Ibraheem Qaisi, Asil Yagmour and 5 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of interventional cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Hossam Alzu'biDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0001-9315-5914
Anan Abu RmilahDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Ikram-Ui HaqDepartment of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Babikir KheiriKnight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
Ahmad Al-AbdouhDepartment of Medicine, Ascension Saint Agnes Hospital, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-2836-0687
Bashar HasanEvidence-Based Practice Research Program, Mayo Clinic, Rochester, MN, USA.
Omar ElsekailyDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Suhaib JaberDepartment of Internal Medicine, Dr. Sulaiman Al Habib Hospital, Riyadh, Saudi Arabia.
Ibraheem QaisiAn-Najah National University School of Medicine, Nablus, State of Palestine.
Asil YagmourAl Quds University School of Medicine, Hebron, State of Palestine.
Hamada DajaniAn-Najah National University School of Medicine, Nablus, State of Palestine.
Azza AhmedDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Ahmed ElhagDepartment of Internal Medicine, Dr. Sulaiman Al Habib Hospital, Riyadh, Saudi Arabia.
Kianoush KashaniDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Abhishek DeshmukhDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USAn-Najah National University · PSAl-Quds University · PSMayo Clinic · USMayo Clinic in Florida · USOregon Health & Science University · USSaint Agnes Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute kidney injury (AKI) is a well-known complication following a transcatheter aortic valve replacement (TAVR) and is associated with higher morbidity and mortality. Objective: We aim to compare the risk of developing AKI after transfemoral (TF), transapical (TA), and transaortic (TAo) approaches following TAVR. Methods: We searched Medline and EMBASE databases from January 2009 to January 2021. We included studies that evaluated the risk of AKI based on different TAVR approaches. After extracting each study's data, we calculated the risk ratio and 95% confidence intervals using RevMan software 5.4. Publication bias was assessed by the forest plot. Results: Thirty-six (36) studies, consisting of 70,406 patients undergoing TAVR were included. Thirty-five studies compared TF to TA, and only seven investigations compared TF to TAo. AKI was documented in 4,857 out of 50,395 (9.6%) patients that underwent TF TAVR compared to 3,155 out of 19,721 (16%) patients who underwent TA-TAVR, with a risk ratio of 0.49 (95% CI, 0.36-0.66; p < 0.00001). Likewise, 273 patients developed AKI out of the 1,840 patients (14.8%) that underwent TF-TAVR in contrast to 67 patients out of the 421 patients (15.9%) that underwent TAo-TAVR, with a risk ratio of 0.51 (95% CI, 0.27-0.98; Conclusion: The risk of post-TAVR AKI is significantly lower in patients who underwent TF-TAVR than those who underwent TA-TAVR or TAo-TAVR.

Indexed as

Acute Kidney InjuryAortic Valve StenosisTranscatheter Aortic Valve ReplacementAortic ValveFemoral ArteryHumansIncidenceRisk AssessmentRisk FactorsTreatment Outcome

Identifiers

PMID36348992
PMCPMC9633203
OpenAlexW4307434360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.